Skip to content
Search

Latest Stories

GPhC announces registration assessment dates

The General Pharmaceutical Council (GPhC) has announced that the provisional registration of pharmacists will be extended to January 2022.

The extension has been made to enable trainee pharmacists from the 2020/21 cohort to apply to join the provisional register once their training is satisfactorily completed.


The pharmacy regulator has also confirmed the dates of the delayed summer and autumn assessments of provisional registrants which will be held from July 27 to 29 and on November 16 respectively.

“The GPhC Council has agreed that provisional registration of pharmacists will be extended to January 2022, to enable trainees from the 2020-21 cohort to apply to join the provisional register once their training is satisfactorily completed, so that they can take up offers of employment at the same time as they usually would, from August 1, 2021,” the regulator said in its latest update.

The extension of provisional registration will make trainees and provisionally registered-pharmacists to wait longer than expected to sit the assessment, join the register, and take up roles as fully-registered pharmacists.

This will also have an impact on employers who would have been expecting newly-qualified pharmacists to join the register from August 2021.

The registration assessment sittings are usually held in June and September. These dates in July and November are the earliest available where Pearson VUE test centres can accommodate the predicted number of candidates under the current social distancing guidelines.

“Candidates on each of the three days will sit a different paper, but we would emphasise that number and types of questions, and the standard required to pass will not change,” the regulator added.

The same eligibility criteria will apply to those planning to join the provisional register in 2021. They will be able to join once they have successfully completed 52 weeks of training (including if they reach 52 weeks after they have sat the registration assessment).

Duncan Rudkin, GPhC Chief Executive, said: “We understand that holding the sittings in July and November will have an impact on pre-registration trainees, provisionally-registered pharmacists and employers. Unfortunately, the pandemic continues to be a significant factor in the logistics of holding assessment sittings and has meant that earlier dates are simply not feasible.

“We regret any challenges this may cause and we hope that extending provisional registration will help mitigate these challenges for trainees and employers. This will also help give potential candidates further options when deciding when they feel fit to sit, depending on their individual circumstances.

“We are committed to learning lessons from feedback from candidates about the forthcoming March assessment and are working with Pearson VUE to improve candidates’ experience of sitting the assessment.”

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less